| Year |
Citation |
Score |
| 2018 |
Connolly B, Isaacs C, Cheng L, Asrani KH, Subramanian RR. SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency. Journal of Nucleic Acids. 2018: 8247935. PMID 30009048 DOI: 10.1155/2018/8247935 |
0.336 |
|
| 2018 |
Asrani KH, Cheng L, Cheng CJ, Subramanian RR. Arginase I mRNA therapy - A novel approach to rescue arginase 1 enzyme deficiency. Rna Biology. PMID 29923457 DOI: 10.1080/15476286.2018.1475178 |
0.329 |
|
| 2018 |
Asrani KH, Farelli JD, Stahley MR, Miller RL, Cheng CJ, Subramanian RR, Brown JM. Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA. Rna Biology. 1-7. PMID 29578372 DOI: 10.1080/15476286.2018.1450054 |
0.364 |
|
| 2018 |
Farelli JD, Asrani KH, Isaacs C, deBear JS, Stahley MR, Shah A, Lasaro MA, Cheng CJ, Subramanian RR. Leveraging Rational Protein Engineering to Improve mRNA Therapeutics. Nucleic Acid Therapeutics. PMID 29437538 DOI: 10.1089/Nat.2017.0697 |
0.366 |
|
| 2012 |
Subramanian RR, Yamakawa A. Combination therapy targeting Raf-1 and MEK causes apoptosis of HCT116 colon cancer cells. International Journal of Oncology. 41: 1855-62. PMID 22922669 DOI: 10.3892/Ijo.2012.1602 |
0.379 |
|
| 2011 |
Moschos SA, Frick M, Taylor B, Turnpenny P, Graves H, Spink KG, Brady K, Lamb D, Collins D, Rockel TD, Weber M, Lazari O, Perez-Tosar L, Fancy SA, Lapthorn C, ... ... Subramanian R, et al. Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 2163-8. PMID 21971426 DOI: 10.1038/Mt.2011.206 |
0.305 |
|
| 2009 |
Titus MA, Tan JA, Gregory CW, Ford OH, Subramanian RR, Fu H, Wilson EM, Mohler JL, French FS. 14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7571-7581. PMID 19996220 DOI: 10.1158/1078-0432.Ccr-08-1976 |
0.467 |
|
| 2004 |
Subramanian RR, Zhang H, Wang H, Ichijo H, Miyashita T, Fu H. Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. Experimental Cell Research. 294: 581-91. PMID 15023544 DOI: 10.1016/J.Yexcr.2003.12.009 |
0.675 |
|
| 2004 |
Titus MA, Gregory CW, Smitherman AB, Subramanian RR, Fu H, Mohler JL, French FS. 582: 14-3-3η Protein Mediates AR Transactivation in Recurrent Prostate Cancer The Journal of Urology. 171: 154-155. DOI: 10.1016/S0022-5347(18)37844-3 |
0.497 |
|
| 2003 |
Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, Roberts TM, Hahn WC. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell. 3: 483-95. PMID 12781366 DOI: 10.1016/S1535-6108(03)00088-6 |
0.324 |
|
| 2002 |
Masters SC, Subramanian RR, Truong A, Yang H, Fujii K, Zhang H, Fu H. Survival-promoting functions of 14-3-3 proteins. Biochemical Society Transactions. 30: 360-5. PMID 12196095 DOI: 10.1042/Bst0300360 |
0.736 |
|
| 2002 |
Furman C, Short SM, Subramanian RR, Zetter BR, Roberts TM. DEF-1/ASAP1 is a GTPase-activating protein (GAP) for ARF1 that enhances cell motility through a GAP-dependent mechanism. The Journal of Biological Chemistry. 277: 7962-9. PMID 11773070 DOI: 10.1074/Jbc.M109149200 |
0.464 |
|
| 2002 |
Masters SC, Subramanian RR, Truong A, Yang H, Fujii K, Zhang H, Fu H. Prosurvival Function of 14-3-3 Proteins Biochemical Society Transactions. 30: A62-A62. DOI: 10.1042/Bst030A062A |
0.709 |
|
| 2001 |
Subramanian RR, Masters SC, Zhang H, Fu H. Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. Experimental Cell Research. 271: 142-51. PMID 11697890 DOI: 10.1006/Excr.2001.5376 |
0.744 |
|
| 2001 |
Chiang CW, Harris G, Ellig C, Masters SC, Subramanian R, Shenolikar S, Wadzinski BE, Yang E. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin- 3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood. 97: 1289-97. PMID 11222372 DOI: 10.1182/Blood.V97.5.1289 |
0.707 |
|
| 2000 |
Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation. Annual Review of Pharmacology and Toxicology. 40: 617-47. PMID 10836149 DOI: 10.1146/Annurev.Pharmtox.40.1.617 |
0.743 |
|
| 1998 |
Subramanian RR, Yang H, Wjicox JN, Masters SC, Fu H. Isoform specificity of 14-3-3 proteins Faseb Journal. 12. |
0.713 |
|
| 1994 |
Wilcox JN, Rodriguez J, Subramanian R, Ollerenshaw J, Zhong C, Hayzer DJ, Horaist C, Hanson SR, Lumsden A, Salam TA, Kelly AB, Harker LA, Runge M. Characterization of thrombin receptor expression during vascular lesion formation Circulation Research. 75: 1029-1038. PMID 7955141 DOI: 10.1161/01.Res.75.6.1029 |
0.329 |
|
| Show low-probability matches. |